Abstract
Mucosal-associated invariant T cells (MAITs) are enriched in the liver and closely related to human hepatocellular carcinoma (HCC), but their role is controversial. Whether and how the plasticity of MAITs modulates HCC progression remain to be explored. Here, we revealed that CD4+ MAITs displaying Th17 features were the major source of IL-17A in human HCC. IL-17A from Th17-polarized CD4+ MAITs promoted HCC progression by enhancing lipid storage and tumor cell proliferation in a PPARα dependent manner. Additionally, we showed that both TCR-dependent and TCR-independent activation signaling induced Th17-polarized CD4+ MAIT differentiation and that strong signaling promoted their differentiation. Moreover, IL-17A production in CD4+ MAITs was promoted by glycolysis via posttranscriptional regulation, and tumor cell-derived kynurenine enhanced glycolysis and IL-17A production through the AHR pathway. These findings demonstrate that the plasticity of MAITs and the generation of CD4+ MAITs promote HCC progression via metabolic crosstalk with tumor cells.

This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout







Data availability
All raw sequencing reads for single-cell RNA-seq data (PRJNA1175005), bulk RNA-seq data (PRJNA1013717), and CUT&Tag-seq data (PRJNA1018210) have been deposited in the National Center for Biotechnology Information Sequence Read Archive. Source data are provided with this paper.
References
Llovet JM, Kelley RK, Villanueva A, Singal AG, Pikarsky E, Roayaie S, et al. Hepatocellular carcinoma. Nat Rev Dis Prim. 2021;7:6 https://doi.org/10.1038/s41572-020-00240-3.
Sperandio RC, Pestana RC, Miyamura BV, Kaseb AO. Hepatocellular carcinoma immunotherapy. Annu Rev Med. 2022;73:267ā78. https://doi.org/10.1146/annurev-med-042220-021121.
Llovet JM, Castet F, Heikenwalder M, Maini MK, Mazzaferro V, Pinato DJ, et al. Immunotherapies for hepatocellular carcinoma. Nat Rev Clin Oncol. 2022;19:151ā72. https://doi.org/10.1038/s41571-021-00573-2.
Provine NM, Klenerman P. MAIT cells in health and disease. Annu Rev Immunol. 2020;38:203ā28. https://doi.org/10.1146/annurev-immunol-080719-015428.
Kjer-Nielsen L, Patel O, Corbett AJ, Le Nours J, Meehan B, Liu L, et al. MR1 presents microbial vitamin B metabolites to MAIT cells. Nature. 2012;491:717ā23. https://doi.org/10.1038/nature11605.
Godfrey DI, Koay HF, McCluskey J, Gherardin NA. The biology and functional importance of MAIT cells. Nat Immunol. 2019;20:1110ā28. https://doi.org/10.1038/s41590-019-0444-8.
Toubal A, Nel I, Lotersztajn S, Lehuen A. Mucosal-associated invariant T cells and disease. Nat Rev Immunol. 2019;19:643ā57. https://doi.org/10.1038/s41577-019-0191-y.
Duan M, Goswami S, Shi JY, Wu LJ, Wang XY, Ma JQ, et al. Activated and exhausted MAIT cells foster disease progression and indicate poor outcome in hepatocellular carcinoma. Clin Cancer Res Off J Am Assoc Cancer Res. 2019;25:3304ā16. https://doi.org/10.1158/1078-0432.CCR-18-3040.
Zheng C, Zheng L, Yoo JK, Guo H, Zhang Y, Guo X, et al. Landscape of infiltrating T cells in liver cancer revealed by single-cell sequencing. Cell. 2017;169:1342ā56 e1316. https://doi.org/10.1016/j.cell.2017.05.035.
Tao H, Pan Y, Chu S, Li L, Xie J, Wang P, et al. Differential controls of MAIT cell effector polarization by mTORC1/mTORC2 via integrating cytokine and costimulatory signals. Nat Commun. 2021;12:2029. https://doi.org/10.1038/s41467-021-22162-8.
Garner LC, Amini A, FitzPatrick M, Lett MJ, Hess GF, Filipowicz Sinnreich M, et al. Single-cell analysis of human MAIT cell transcriptional, functional and clonal diversity. Nat Immunol. 2023;24:1565ā78. https://doi.org/10.1038/s41590-023-01575-1.
Magalhaes I, Pingris K, Poitou C, Bessoles S, Venteclef N, Kiaf B, et al. Mucosal-associated invariant T cell alterations in obese and type 2 diabetic patients. J Clin Investig. 2015;125:1752ā62. https://doi.org/10.1172/JCI78941.
Carolan E, Tobin LM, Mangan BA, Corrigan M, Gaoatswe G, Byrne G, et al. Altered distribution and increased IL-17 production by mucosal-associated invariant T cells in adult and childhood obesity. J Immunol. 2015;194:5775ā80. https://doi.org/10.4049/jimmunol.1402945.
Toubal A, Kiaf B, Beaudoin L, Cagninacci L, Rhimi M, Fruchet B, et al. Mucosal-associated invariant T cells promote inflammation and intestinal dysbiosis leading to metabolic dysfunction during obesity. Nat Commun. 2020;11:3755. https://doi.org/10.1038/s41467-020-17307-0.
Willing A, Jager J, Reinhardt S, Kursawe N, Friese MA. Production of IL-17 by MAIT cells is increased in multiple sclerosis and is associated with IL-7 receptor expression. J Immunol. 2018;200:974ā82. https://doi.org/10.4049/jimmunol.1701213.
Zhang LW, et al. Expression of interleukin-17 in primary Sjogrenās syndrome and the correlation with disease severity: A systematic review and meta-analysis. Scand J Immunol. 2018;87:e12649. https://doi.org/10.1111/sji.12649.
Rha MS, Yoon YH, Koh JY, Jung JH, Lee HS, Park SK, et al. IL-17A-producing sinonasal MAIT cells in patients with chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol. 2022;149:599ā609.e597. https://doi.org/10.1016/j.jaci.2021.07.037.
Lu B, Liu M, Wang J, Fan H, Yang D, Zhang L, et al. IL-17 production by tissue-resident MAIT cells is locally induced in children with pneumonia. Mucosal Immunol. 2020;13:824ā35. https://doi.org/10.1038/s41385-020-0273-y.
Li X, Fu S, Cheng H, Ma M, Song Z, Li J, et al. Differentiation of type 17 mucosal-associated invariant T cells in circulation contributes to the severity of sepsis. Am J Pathol. 2024;194:1248ā61. https://doi.org/10.1016/j.ajpath.2024.03.010.
Fu S, Liu M, Zhu C, Zhang H, Zhao C, Xie Y, et al. Regulatory MAIT cells controlled by beta1 adrenergic receptor signaling contribute to hepatocellular carcinoma progression. Hepatology. 2023;78:72ā87. https://doi.org/10.1097/HEP.0000000000000014.
Arner EN, Rathmell JC. Metabolic programming and immune suppression in the tumor microenvironment. Cancer cell. 2023;41:421ā33. https://doi.org/10.1016/j.ccell.2023.01.009.
DePeaux K, Delgoffe GM. Metabolic barriers to cancer immunotherapy. Nat Rev Immunol. 2021;21:785ā97. https://doi.org/10.1038/s41577-021-00541-y.
OāSullivan D, Sanin DE, Pearce EJ, Pearce EL. Metabolic interventions in the immune response to cancer. Nat Rev Immunol. 2019;19:324ā35. https://doi.org/10.1038/s41577-019-0140-9.
Kao KC, Vilbois S, Tsai CH, Ho PC. Metabolic communication in the tumour-immune microenvironment. Nat Cell Biol. 2022;24:1574ā83. https://doi.org/10.1038/s41556-022-01002-x.
Roy DG, Kaymak I, Williams KS, Ma EH, Jones RG. Immunometabolism in the tumor microenvironment. Annu Rev Cancer Biol. 2021;5:137ā59.
Dias J, Boulouis C, Gorin JB, van den Biggelaar R, Lal KG, Gibbs A, et al. The CD4(-)CD8(-) MAIT cell subpopulation is a functionally distinct subset developmentally related to the main CD8(+) MAIT cell pool. Proc Natl Acad Sci USA. 2018;115:E11513āE22. https://doi.org/10.1073/pnas.1812273115.
Martin-Perez M, Urdiroz-Urricelqui U, Bigas C, Benitah SA. The role of lipids in cancer progression and metastasis. Cell Metab. 2022;34:1675ā99. https://doi.org/10.1016/j.cmet.2022.09.023.
Bai D-S, Zhang C, Chen P, Jin S-J, Jiang G-Q. The prognostic correlation of AFP level at diagnosis with pathological grade, progression, and survival of patients with hepatocellular carcinoma. Sci Rep. 2017;7:12870. https://doi.org/10.1038/s41598-017-12834-1.
Yoshikawa M, Morine Y, Ikemoto T, Imura S, Higashijima J, Iwahashi S, et al. Elevated preoperative serum CEA level is associated with poor prognosis in patients with hepatocellular carcinoma through the epithelialāmesenchymal transition. Anticancer Res. 2017;37:1169ā76. https://doi.org/10.21873/anticanres.11430.
Zhang W, Wang Y, Dong X, Yang B, Zhou H, Chen L, et al. Elevated serum CA19-9 indicates severe liver inflammation and worse survival after curative resection in hepatitis B-related hepatocellular carcinoma. Biosci Trends. 2021;15:397ā405. https://doi.org/10.5582/bst.2021.01517.
Ruf B, Bruhns M, Babaei S, Kedei N, Ma L, Revsine M, et al. Tumor-associated macrophages trigger MAIT cell dysfunction at the HCC invasive margin. Cell. 2023;186:3686ā705.e3632. https://doi.org/10.1016/j.cell.2023.07.026.
Lafita-Navarro MC, Perez-Castro L, Zacharias LG, Barnes S, DeBerardinis RJ, Conacci-Sorrell M. The transcription factors aryl hydrocarbon receptor and MYC cooperate in the regulation of cellular metabolism. J Biol Chem. 2020;295:12398ā407. https://doi.org/10.1074/jbc.AC120.014189.
Mascanfroni ID, Takenaka MC, Yeste A, Patel B, Wu Y, Kenison JE, et al. Metabolic control of type 1 regulatory T cell differentiation by AHR and HIF1-α. Nat Med. 2015;21:638ā46. https://doi.org/10.1038/nm.3868.
Opitz CA, Litzenburger UM, Sahm F, Ott M, Tritschler I, Trump S, et al. An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor. Nature. 2011;478:197ā203. https://doi.org/10.1038/nature10491.
Liu Y, Liang X, Dong W, Fang Y, Lv J, Zhang T, et al. Tumor-repopulating cells induce PD-1 expression in CD8(+) T cells by transferring kynurenine and AhR Activation. Cancer cell. 2018;33:480ā94.e487. https://doi.org/10.1016/j.ccell.2018.02.005.
Wegener M, Dietz KJ. The mutual interaction of glycolytic enzymes and RNA in post-transcriptional regulation. RNA. 2022;28:1446ā68. https://doi.org/10.1261/rna.079210.122.
Chang CH, Curtis JD, Maggi LB Jr, Faubert B, Villarino AV, O'Sullivan D, et al. Posttranscriptional control of T cell effector function by aerobic glycolysis. Cell. 2013;153:1239ā51. https://doi.org/10.1016/j.cell.2013.05.016.
Castello A, Hentze MW, Preiss T. Metabolic Enzymes Enjoying New Partnerships as RNA-Binding Proteins. Trends Endocrinol Metab: TEM. 2015;26:746ā57. https://doi.org/10.1016/j.tem.2015.09.012.
De Rosa V, Galgani M, Porcellini A, Colamatteo A, Santopaolo M, Zuchegna C, et al. Glycolysis controls the induction of human regulatory T cells by modulating the expression of FOXP3 exon 2 splicing variants. Nat Immunol. 2015;16:1174ā84. https://doi.org/10.1038/ni.3269.
Millet P, Vachharajani V, McPhail L, Yoza B, McCall CE. GAPDH Binding to TNF-alpha mRNA contributes to posttranscriptional repression in monocytes: a novel mechanism of communication between inflammation and metabolism. J Immunol. 2016;196:2541ā51. https://doi.org/10.4049/jimmunol.1501345.
Zhao J, Chen X, Herjan T, Li X. The role of interleukin-17 in tumor development and progression. J Exp Med. 2020;217 https://doi.org/10.1084/jem.20190297.
Ma S, Cheng Q, Cai Y, Gong H, Wu Y, Yu X, et al. IL-17A produced by gammadelta T cells promotes tumor growth in hepatocellular carcinoma. Cancer Res. 2014;74:1969ā82. https://doi.org/10.1158/0008-5472.CAN-13-2534.
Gallagher C, Mahon JM, O'Neill C, Cassidy FC, Dunbar H, De Barra C, et al. Mucosal-associated invariant T cells are altered in patients with Hidradenitis Suppurativa and contribute to the inflammatory milieu. J Investig Dermatol. 2023;143:1094ā97.e1092. https://doi.org/10.1016/j.jid.2022.11.011.
Priya R, Brutkiewicz RR. MR1 tetramer-based artificial APCs expand MAIT cells from human peripheral blood that effectively kill glioblastoma cells. Immunohorizons. 2021;5:500ā11. https://doi.org/10.4049/immunohorizons.2100003.
Labuz D, Cacioppo J, Li K, AubĆ© J, Leung DT. Enhancing mucosal-associated invariant T cell function and expansion with human selective serum. ImmunoHorizons. 2023;7:116ā24. https://doi.org/10.4049/immunohorizons.2200082.
Kedia-Mehta N, Pisarska MM, Rollings C, O'Neill C, De Barra C, Foley C, et al. The proliferation of human mucosal-associated invariant T cells requires a MYC-SLC7A5-glycolysis metabolic axis. Sci Signal. 2023;16:eabo2709 https://doi.org/10.1126/scisignal.abo2709.
O'brien A, Loftus RM, Pisarska MM, Tobin LM, Bergin R, Wood N, et al. Obesity reduces mTORC1 activity in mucosal-associated invariant T cells, driving defective metabolic and functional responses. J Immunol. 2019;202:3404ā11. https://doi.org/10.4049/jimmunol.1801600.
Vitiello GA, Miller G. Targeting the interleukin-17 immune axis for cancer immunotherapy. J Exp Med. 2020;217 https://doi.org/10.1084/jem.20190456.
Acknowledgements
We thank the NIH Tetramer Core Facility for providing the hMR1-5-OP-RU tetramer and hMR1-6-FP tetramer. We thank Professor Zeming Zhang for helping us provide the scRNA-seq data. This work was supported by the National Natural Science Foundation of China (32325020, 92254304, and 82372778), the Strategic Priority Research Program of the Chinese Academy of Sciences (Grant No. XDB0940202), the CAS Project for Young Scientists in Basic Research (YSBR-074), the Key Science & Technology Project of Anhui Province (202523n10050009), and the Fundamental Research Funds for the Central Universities (WK9100250109).
Author information
Authors and Affiliations
Contributions
S.C.F. and L.B. conceived the idea and wrote the manuscript. S.C.F., Y.B.Q., L.X.L., H.W., H.M.Z., and L.B. designed the experiments and discussed the results. S.C.F., M.Y.T., C.F.Z., M.Y.S., J.P., Y.W.Z., X.H.W., W.H.J., and S.C. performed the experiments, S.W.C., X.M.C., Y.S.C., L.J.C., T.C.J., Z.G.T, Y.B.S., Y.B.Q., L.X.L. and H.W. provided materials.
Corresponding authors
Ethics declarations
Competing interests
The authors declare that they have no competing interests. Z.G.T. is the Co-Editor-in-Chief of Cellular & Molecular Immunology, and L.B. is an editorial board member of Cellular & Molecular Immunology, but they have not been involved in the peer review or the decision-making of the article.
Additional information
Publisherās note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Fu, S., Tang, M., Zhao, C. et al. MAIT cell plasticity generates CD4+ MAIT cells that promote HCC progression via metabolic crosstalk with tumor cells. Cell Mol Immunol (2026). https://doi.org/10.1038/s41423-026-01409-8
Received:
Accepted:
Published:
Version of record:
DOI: https://doi.org/10.1038/s41423-026-01409-8